APOA1 and coronary artery disorder: Polymorphism in genes such as β fibrinogen [8] apolipoprotein A-I [9] heme oxygenase-1 [10], PON1 and PON2 [11], PAI-1 [12], MMP-2, MMP-3, MMP-9 and MMP-12 [13], NADH/NADPH oxidase [14] and angiotensin II type 1 receptor [15] were responsible for the progression of CAD.